Pub. Date : 2009 Dec 2
PMID : 19954513
7 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy. | Fluorouracil | tumor protein p53 | Homo sapiens |
| 2 | Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy. | Fluorouracil | tumor protein p53 | Homo sapiens |
| 3 | Previous in vitro and clinical investigations reported that CRC patients with wild-type p53 gene (TP53)-tumors benefit from 5-fluorouracil (5-FU) based chemotherapy, while those with mutated TP53-tumors do not. | Fluorouracil | tumor protein p53 | Homo sapiens |
| 4 | Previous in vitro and clinical investigations reported that CRC patients with wild-type p53 gene (TP53)-tumors benefit from 5-fluorouracil (5-FU) based chemotherapy, while those with mutated TP53-tumors do not. | Fluorouracil | tumor protein p53 | Homo sapiens |
| 5 | Previous in vitro and clinical investigations reported that CRC patients with wild-type p53 gene (TP53)-tumors benefit from 5-fluorouracil (5-FU) based chemotherapy, while those with mutated TP53-tumors do not. | Fluorouracil | tumor protein p53 | Homo sapiens |
| 6 | Previous in vitro and clinical investigations reported that CRC patients with wild-type p53 gene (TP53)-tumors benefit from 5-fluorouracil (5-FU) based chemotherapy, while those with mutated TP53-tumors do not. | Fluorouracil | tumor protein p53 | Homo sapiens |
| 7 | We raised a possibility that Dukes" stage C colorectal cancer patients with tumors carrying TP53 mutation, especially the P72 allele, benefited from 5-FU based postoperative chemotherapy. | Fluorouracil | tumor protein p53 | Homo sapiens |